• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $DYNT

    Dynatronics Corporation

    Subscribe to $DYNT
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also provides power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, recumbent bikes, and other related equipment. In addition, it offers therapeutic modality devices, such as electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. Further, the company provides clinical supplies, including exercise bands and tubing, topical analgesics, lotions and gels, orthopedic bracing, paper products, athletic tapes, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, and athletic trainers, sports medicine practitioners, hospitals, clinics, and consumers, as well as online. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Eagan, Minnesota.

    IPO Year:

    Exchange: NASDAQ

    Website: dynatronics.com

    Recent Analyst Ratings for Dynatronics Corporation

    DatePrice TargetRatingAnalyst
    See more ratings

    Dynatronics Corporation Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      2/14/23 12:35:29 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      2/13/23 12:33:51 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      1/14/22 12:22:28 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      2/16/21 3:06:29 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    Dynatronics Corporation SEC Filings

    See more
    • SEC Form 10-Q filed by Dynatronics Corporation

      10-Q - DYNATRONICS CORP (0000720875) (Filer)

      5/12/25 4:00:27 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation filed SEC Form 8-K: Leadership Update

      8-K - DYNATRONICS CORP (0000720875) (Filer)

      5/9/25 8:00:26 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation filed SEC Form 8-K: Leadership Update

      8-K - DYNATRONICS CORP (0000720875) (Filer)

      4/18/25 7:30:18 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - DYNATRONICS CORP (0000720875) (Filer)

      4/4/25 9:00:28 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by Dynatronics Corporation

      10-Q - DYNATRONICS CORP (0000720875) (Filer)

      2/14/25 5:00:24 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - DYNATRONICS CORP (0000720875) (Filer)

      12/9/24 9:31:20 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by Dynatronics Corporation

      10-Q - DYNATRONICS CORP (0000720875) (Filer)

      11/14/24 12:02:13 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by Dynatronics Corporation

      DEFA14A - DYNATRONICS CORP (0000720875) (Filer)

      10/25/24 12:02:33 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form DEF 14A filed by Dynatronics Corporation

      DEF 14A - DYNATRONICS CORP (0000720875) (Filer)

      10/25/24 12:00:44 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - DYNATRONICS CORP (0000720875) (Filer)

      9/24/24 3:01:08 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    Dynatronics Corporation Leadership Updates

    Live Leadership Updates

    See more
    • Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

      Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

      1/8/24 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Appointment of Dr. Christopher von Jako as new CEO

      Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

      6/21/23 9:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

      Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

      5/18/23 8:05:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    Dynatronics Corporation Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Staats Ryan Edward claimed ownership of 40 shares (SEC Form 3)

      3 - DYNATRONICS CORP (0000720875) (Issuer)

      5/12/25 4:00:53 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Director Enright Erin S. acquired 739,014 shares (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      4/3/25 3:12:03 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Large owner Provco Ventures 1 Lp acquired 369,292 shares, increasing direct ownership by 29% to 1,633,439 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      4/3/25 3:10:57 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Large owner Essig Stuart acquired 739,014 shares, increasing direct ownership by 30% to 2,689,561 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      4/3/25 3:09:35 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • CEO & President Baker Brian D. acquired 51,831 shares, increasing direct ownership by 30% to 227,366 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      4/3/25 3:06:24 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Large owner Provco Ventures 1 Lp acquired 315,721 shares, increasing direct ownership by 33% to 1,264,147 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      1/6/25 2:09:54 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Large owner Essig Stuart acquired 633,810 shares, increasing direct ownership by 34% to 2,074,076 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      1/6/25 2:08:15 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Director Enright Erin S. acquired 633,810 shares, increasing direct ownership by 7% to 31,124 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      1/6/25 2:06:58 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Director Holtz David B was granted 2,000 units of Common, increasing direct ownership by 7% to 30,968 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      1/6/25 2:05:34 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • CEO & President Baker Brian D. acquired 44,313 shares, increasing direct ownership by 34% to 175,535 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      1/6/25 2:04:55 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    Dynatronics Corporation Press Releases

    Fastest customizable press release news feed in the world

    See more

    Dynatronics Corporation Financials

    Live finance-specific insights

    See more
    • Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

      Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

      1/8/24 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Appointment of Dr. Christopher von Jako as new CEO

      Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

      6/21/23 9:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

      Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

      5/18/23 8:05:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

      Eagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:Competitive acquisitions by a significant rehabilitation customer; Reduction in specific SKUs of an OEM customer for the

      5/11/23 7:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

      Eagan, Minnesota--(Newsfile Corp. - April 27, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its third quarter of fiscal year 2023 on Thursday, May 11, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, May 11, 2023, to review its third quarter results.Interested persons may access the live conference call by dialing 1-800-319-4610 (U.S./Canada calle

      4/27/23 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Announces Participation in Investor Conferences

      Canaccord Genuity 2023 Musculoskeletal Conference: March 7, 2023Roth Capital Conference: March 12 - 14, 2023Investor Summit: March 29, 2023Eagan, Minnesota--(Newsfile Corp. - March 2, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that management will participate in three investor conferences in March 2023, to provide an update on the company's business. John Krier, President and CEO of Dynatronics Corporation, will participate in the Canaccord Genuity 2023 Musculoskeletal Conference on March 7, 2023, held in Las Vegas, and will also participate in the Roth Capital Conference on March

      3/2/23 7:30:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

      EAGAN, MN / ACCESSWIRE / February 9, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.CEO Commentary"The year-over-year improvement in gross margin of 8.4% or nearly $1.0 million in gross profit was a solid improvement. We are pleased with our progression, but we have more work to do. New, targeted, and innovative, product releases are the third pillar of our gross margin improvement plan, and we plan to continue to improve our performance in

      2/9/23 7:30:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Announces Reverse Stock Split

      EAGAN, MN / ACCESSWIRE / February 1, 2023 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that it will effect a 1-for-5 reverse stock split of its outstanding common stock, effective at 5:00 p.m. (ET) on February 1, 2023. Dynatronics' common stock will continue to trade on the NASDAQ under the symbol "DYNT" under a new CUSIP number, 268157500. Dynatronics' common stock will begin trading on a reverse stock split-adjusted basis on the NASDAQ when the market opens on February 2, 2023.The reverse stock split was implemented to bring the Company into compliance with NASDAQ's minimum bid price req

      2/1/23 1:00:00 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Second Quarter Results

      EAGAN, MN / ACCESSWIRE / January 26, 2023 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its second quarter of fiscal year 2023 on Thursday, February 9, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, February 9, 2023, to review its second quarter results.Interested persons may access the live conference call by dialing 888-506-0062 (U.S./Canada callers

      1/26/23 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports First Quarter Fiscal Year 2023 Financial Results and Business Highlights

      EAGAN, MN / ACCESSWIRE / November 10, 2022 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its first quarter of fiscal year 2023 ended September 30, 2022, and provided an update on recent business highlights.CEO Commentary"We continue to execute against our differentiated strategy which has led to a sequential increase of 6.8%-points in gross margin from the fourth quarter of fiscal year 2022. The first quarter of fiscal year 2023 represented the sixth consecutive quarter of exceeding the market or our baseline net sales expectation set in

      11/10/22 7:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

      Eagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:Competitive acquisitions by a significant rehabilitation customer; Reduction in specific SKUs of an OEM customer for the

      5/11/23 7:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

      Eagan, Minnesota--(Newsfile Corp. - April 27, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its third quarter of fiscal year 2023 on Thursday, May 11, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, May 11, 2023, to review its third quarter results.Interested persons may access the live conference call by dialing 1-800-319-4610 (U.S./Canada calle

      4/27/23 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

      EAGAN, MN / ACCESSWIRE / February 9, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.CEO Commentary"The year-over-year improvement in gross margin of 8.4% or nearly $1.0 million in gross profit was a solid improvement. We are pleased with our progression, but we have more work to do. New, targeted, and innovative, product releases are the third pillar of our gross margin improvement plan, and we plan to continue to improve our performance in

      2/9/23 7:30:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Second Quarter Results

      EAGAN, MN / ACCESSWIRE / January 26, 2023 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its second quarter of fiscal year 2023 on Thursday, February 9, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, February 9, 2023, to review its second quarter results.Interested persons may access the live conference call by dialing 888-506-0062 (U.S./Canada callers

      1/26/23 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports First Quarter Fiscal Year 2023 Financial Results and Business Highlights

      EAGAN, MN / ACCESSWIRE / November 10, 2022 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its first quarter of fiscal year 2023 ended September 30, 2022, and provided an update on recent business highlights.CEO Commentary"We continue to execute against our differentiated strategy which has led to a sequential increase of 6.8%-points in gross margin from the fourth quarter of fiscal year 2022. The first quarter of fiscal year 2023 represented the sixth consecutive quarter of exceeding the market or our baseline net sales expectation set in

      11/10/22 7:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Schedules Conference Call and Webcast to Report First Quarter Results for Fiscal 2023

      EAGAN, MN / ACCESSWIRE / November 1, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its first quarter of fiscal year 2023 on Thursday, November 10, 2022 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, November 10, 2022, to review its first quarter results.Interested persons may access the live conference call by dialing 888-506-0062 (U.S./Canada callers

      11/1/22 7:30:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Business Highlights

      EAGAN, MN / ACCESSWIRE / September 22, 2022 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an update on recent business highlights.CEO Commentary"The fourth quarter of fiscal year 2022 represented the fifth consecutive quarter of exceeding the market and our baseline net sales expectation. Net sales growth of 14% in the fourth quarter relative to continued product net sales in the same period in the prior year was a result of our customers' positive reaction to our updat

      9/22/22 7:30:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Schedules Conference Call and Webcast to Report Results for Fourth Quarter and Fiscal Year 2022

      EAGAN, MN / ACCESSWIRE / September 8, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its fourth quarter and fiscal year ended June 30, 2022 on Thursday, September 22, 2022 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, September 22, 2022 to review its fourth quarter and fiscal year 2022 results.Interested persons may access the live conference call by

      9/8/22 8:30:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Third Quarter Financial Results

      EAGAN, MN / ACCESSWIRE / May 12, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results and business highlights for its third quarter of fiscal year 2022 for the period ended March 31, 2022.CEO Commentary"Customer and dealer reaction to Dynatronics' business transformation and market share gains, combined with the favorable market environment, are driving sales to outpace the market and our baseline sales expectation for the fourth consecutive quarter," said John Krier, Chief Executive Officer of Dynatronics. "We expect approximately 16% sales growth in the fourth quarter relat

      5/12/22 7:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Schedules Conference Call and Webcast to Provide Business Update and Discuss Third Quarter of Fiscal Year 2022 Results

      EAGAN, MN / ACCESSWIRE / April 28, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its fiscal third quarter period ended March 31, 2022 on Thursday, May 12, 2022 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 10:00 AM ET on Thursday, May 12, 2022 to review its third quarter of fiscal year 2022 results.Interested persons may access the live conference call by dialing 888-506-00

      4/28/22 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care